NGM BIOPHARMACEUTICALS INC (22) | Uncategorized (6)
Recent Contracts
-
Amendment No. 9 on November
(Filed With SEC on March 1, 2022)
-
Offer Letter Agreement, by and between the Registrant and Hsiao D. Lieu, M.D., dated as of January 16, 2019
(Filed With SEC on May 6, 2021)
-
Offer Letter Agreement, by and between the Registrant and Valerie L. Pierce, dated as of August 6, 2019, and related information
(Filed With SEC on May 6, 2021)
-
Letter Agreement, dated as of March 12, 2021, by and between Merck Sharp & Dohme Corp. and NGM Biopharmaceuticals, Inc
(Filed With SEC on March 15, 2021)
-
Offer Letter Agreement, by and between the Registrant and Siobhan Nolan Mangini, dated as of May 20, 2020
(Filed With SEC on August 12, 2020)
-
Letter Agreement, by and between NGM Biopharmaceuticals, Inc. and Merck Sharp & Dohme Corp., dated as of March 15, 2019
(Filed With SEC on March 25, 2019)